J.A, A. M. D. A. L. X. C. V. C. A. G. E. L. B. M. S. O. J. P. R. P. V. W. S. F. J. S. K. R. (2025). Population pharmacokinetics of caspofungin in critically ill patients receiving extracorporeal membrane oxygenation—an ASAP ECMO study. Antimicrobial Agents and Chemotherapy, 69(2), . https://doi.org/10.1128/aac.01435-24
Chicagoスタイル(17版)引用形式J.A, Abdul-Aziz M.H.; Diehl A.; Liu X.; Cheng V.; Corley A.; Gilder E.; Levkovich B.; McGuinness S.; Ordonez J.; Parke R.; Pellegrino V.; Wallis S.C.; Fraser J.F.; Shekar K.; Roberts. "Population Pharmacokinetics of Caspofungin in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation—an ASAP ECMO Study." Antimicrobial Agents and Chemotherapy 69, no. 2 (2025). https://doi.org/10.1128/aac.01435-24.
MLA(8版)引用形式J.A, Abdul-Aziz M.H.; Diehl A.; Liu X.; Cheng V.; Corley A.; Gilder E.; Levkovich B.; McGuinness S.; Ordonez J.; Parke R.; Pellegrino V.; Wallis S.C.; Fraser J.F.; Shekar K.; Roberts. "Population Pharmacokinetics of Caspofungin in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation—an ASAP ECMO Study." Antimicrobial Agents and Chemotherapy, vol. 69, no. 2, 2025, https://doi.org/10.1128/aac.01435-24.